Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 242,851Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1GENZYME

02 1DR REDDYS

03 1AMNEAL

04 1EUGIA PHARMA

05 1GLAND

06 1MEITHEAL

07 1MSN

08 1TEVA PHARMS USA INC

09 1ZYDUS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code : AP

PLERIXAFOR

Brand Name : MOZOBIL

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2008-12-15

Application Number : 22311

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AP

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

RLD : No

TE Code : AP

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2023-07-24

Application Number : 205182

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

Dr Reddy Company Banner

03

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2023-07-24

Application Number : 215334

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

04

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2023-07-24

Application Number : 213672

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2024-05-03

Application Number : 206644

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2023-07-24

Application Number : 215698

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2023-07-24

Application Number : 211901

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2023-07-24

Application Number : 205197

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PLERIXAFOR

Brand Name : PLERIXAFOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 24MG/1.2ML (20MG/ML)

Approval Date : 2023-07-26

Application Number : 208980

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank